Polyrizon Taps Global CRO to Run Key Preclinical Safety Studies Ahead of First Clinical Trials
at www.tipranks.com (Tue, 17-Mar 8:58 AM)
Market Chameleon (Wed, 4-Feb 8:03 AM)
PL-14 Outperforms HPMC: Polyrizon’s Pre-Clinical Study Shows Markedly Superior Allergen Blocking
Market Chameleon (Mon, 5-Jan 9:27 AM)
PLRZ’s Nasal Spray Stands Out as Flu Surge Drives Interest in New Layered Defenses
Market Chameleon (Fri, 2-Jan 11:49 AM)
Polyrizon Eyes Revenue-Generating Real Asset Investments While Maintaining Biotech Focus
Market Chameleon (Mon, 29-Dec 8:18 AM)
PL-16 Viral Blocker Shows Over 90% Efficacy: Polyrizon Takes Next FDA Step Amid Rising Flu Season
Market Chameleon (Mon, 22-Dec 11:03 AM)
